Literature DB >> 23119935

Osteoclastoma of temporal bone.

T K Hazra1.   

Abstract

A 20 year male presented with a gradually increasing painless swelling at right temporal region with progressive hearing loss conductive in type. On plain X-ray-a wide radio translucent area of bone destruction was noted. The mass was excised as much as possible via post-auricular incision extending antiriorly toward the zygomatic root.Histopathological examination showed the features suggestive of osteoclastoma. Post-operative radiation was administered to deal with the remaining mass there was no recurrence of growth even.

Entities:  

Year:  2003        PMID: 23119935      PMCID: PMC3450954          DOI: 10.1007/BF02968753

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  7 in total

Review 1.  Giant cell reparative granuloma outside the jaw bone. Diagnostic criteria and review of the literature with the first case described in the temporal bone.

Authors:  S Hirschl; A Katz
Journal:  Hum Pathol       Date:  1974-03       Impact factor: 3.466

2.  Giant-cell tumor: a study of 195 cases.

Authors:  D C Dahlin; R E Cupps; E W Johnson
Journal:  Cancer       Date:  1970-05       Impact factor: 6.860

3.  Giant cell tumor of the sphenoid bone. A case report and review of the literature.

Authors:  W E Emley
Journal:  Arch Otolaryngol       Date:  1971-10

4.  Giant cell tumor involving the middle ear.

Authors:  H Rosenwasser
Journal:  Arch Otolaryngol       Date:  1969-12

5.  Giant cell tumors of the sphenoid bone.

Authors:  J D Geissger; E B Siqueira; E R Ross
Journal:  J Neurosurg       Date:  1970-06       Impact factor: 5.115

6.  Giant cell tumors of the calvaria.

Authors:  C Arseni; L Horvath; M Maretsis; N Carp
Journal:  J Neurosurg       Date:  1975-05       Impact factor: 5.115

7.  True giant-cell tumour of the mastoid. A case report.

Authors:  I Daniilidis; M Tsalighopoulos; C Themelis; A Vartholomeos
Journal:  J Laryngol Otol       Date:  1981-08       Impact factor: 1.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.